M. Samama

发表

Familial and constitutional bleeding disorder due to platelet cyclo‐oxygenase deficiency

B. Vargaftig, M. Chignard, F. Fouque, 1983, American journal of hematology.

Prevention of venous thromboembolism after surgery: A review of enoxaparin

J. Hirsh, G. Lowe, A. Berstad, 1992, The British journal of surgery.

Prognostic factors for retinal vein occlusion: prospective study of 175 cases.

G. Coscas, M. Samama, A. Chabanel, 1996, Ophthalmology.

Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cases of cerebral venous thrombosis.

F. Chédru, M. Bousser, M. Samama, 1996, Stroke.

A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group.

A. Turpie, A. Cohen, M. Samama, 1999, The New England journal of medicine.

Prevention and treatment of venous thromboembolism--International Consensus Statement.

P Prandoni, G D Lowe, D Bergqvist, 2013, International angiology : a journal of the International Union of Angiology.

Levels of factor VIIc associated with decreased tissue factor pathway inhibitor and increased plasminogen activator inhibitor-1 in dyslipidemias.

A. Basdevant, L. Bara, M. Samama, 1996, Arteriosclerosis, thrombosis, and vascular biology.

Biochemical and pharmacologic rationale for the development of a synthetic heparin pentasaccharide.

M. Samama, J. Fareed, W. Jeske, 1997, Thrombosis research.

An epidemiologic study of risk factors for deep vein thrombosis in medical outpatients: the Sirius study.

M. Samama, M. Samama, 2000, Archives of internal medicine.

Prevention and Treatment of Venous and Arterial Thrombosis in Patients with Specific Conditions: Diabetes, Hypercoagulable States, Pregnancy, and Renal Insufficiency

M. Samama, J. Conard, G. Gerotziafas, 2012 .

Thrombophilia and venous thromboembolism. International consensus statement. Guidelines according to scientific evidence.

A. Nicolaides, P. Prandoni, K. Myers, 2005, International angiology : a journal of the International Union of Angiology.

Hemostatic enzyme generation in the blood of patients with hereditary protein C deficiency.

R. Bertina, K. Bauer, R. Rosenberg, 1988, Blood.

Thrombocytopenia associated with low-molecular-weight heparin

J. Bertrand, T. Lecompte, N. Stieltjes, 1991, The Lancet.

The role of abnormalities in the anticoagulant and fibrinolytic systems in retinal vascular occlusions.

M. Samama, A. K. Vine, M. Samama, 1993, Survey of ophthalmology.

Acquired von willebrand disease: Correction of hemostatic defect by high‐dose intravenous immunoglobulins

C. Girard-Longhini, A. Delmer, R. Zittoun, 1992, American journal of hematology.

A randomized, double-masked study on the treatment of retinal vein occlusion with troxerutin.

G. Coscas, M. Samama, A. Chabanel, 1994, American journal of ophthalmology.

Pathobiology of thrombin in acute coronary syndromes.

M. Seghatchian, M. Samama, Richard C. Becker, 1998, American heart journal.

Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

M. Samama, Trevor Baglin, David A Garcia, 2012, Chest.

Thrombocytopenia in venocclusive disease after bone marrow transplantation or chemotherapy.

R. Zittoun, G. Andreu, B. Rio, 1986, Blood.

Normalization of markers of coagulation activation with a purified protein C concentrate in adults with homozygous protein C deficiency.

J. Griffin, A. Gruber, K. Bauer, 1993, Blood.

New antithrombotic drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

J. Eikelboom, M. Samama, J. Weitz, 2012, Chest.

Report of the Subcommittee of Control of Anticoagulation on the determination of the anticoagulant effects of rivaroxaban

S. Schulman, J. Harenberg, S. Marx, 2012, Journal of thrombosis and haemostasis : JTH.

Evaluation of the prothrombin time for measuring rivaroxaban plasma concentrations using calibrators and controls

E. Perzborn, T. Spiro, L. Le Flem, 2012, Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.

Prophylaxis of venous thromboembolism in medical patients

M. Samama, G. Gerotziafas, M. Samama, 2004, Current opinion in pulmonary medicine.

Correlation between anti-Xa and occurrence of thrombosis and haemorrhage in post-surgical patients treated with either Logiparin (LMWH) or unfractionated heparin. Post-surgery Logiparin Study Group.

M. Samama, A. Leizorovicz, L. Bara, 1992, Thrombosis research.

Factor VII activation and menopausal status.

L. Guize, C. Bonithon-Kopp, M. Samama, 1990, Thrombosis research.

Serum phospholipids are the main environmental determinants of activated factor VII in the most common FVII genotype

M. Samama, ° °, Flavia Chiarotti, 1999 .

Interactions of anticoagulant insoluble modified polystyrene resins with plasmatic proteins.

M. Samama, M. Jozefowicz, L. Bara, 1982, Thrombosis research.

Original Article: Streptokinase Modifies in Vitro Platelet Aggregation by Two Mechanisms: Reduced Aggregation due to Fibrinogenolysis and Enhanced Aggregation via an Immunological Reaction.

G. Helft, M. Samama, T. Lecompte, 1995, Platelets.

Heparin-induced thrombocytopenia: laboratory diagnosis and management.

M. Horellou, I. Elalamy, J. Conard, 2000, Annals of medicine.

Plasma TFPI activity after intravenous injection of pentasaccharide (PS) and unfractionated heparin in rabbits.

M. Bloch, M. Samama, L. Bara, 1994, Thrombosis Research.